img

Global Equine Influenza Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Equine Influenza Vaccine Market Insights, Forecast to 2034

Equine influenza (horse flu) is the disease caused by strains of influenza A that are enzootic in horse species. Equine influenza occurs globally, previously caused by two main strains of virusequine-1 (H7N7) and equine-2 (H3N8). The World Organisation for Animal Health now considers H7N7 strains likely to be extinct since these strains have not been isolated for over 20 years. Predominant international circulating H3N8 strains are Florida sublineage of the American lineage; clade 1 predominates in the Americas and clade 2 in Europe. (Elton and Cullinane, 2013; Paillot, 2014; Slater et al., 2013[4]). The disease has a nearly 100% infection rate in an unvaccinated horse population with no prior exposure to the virus.
Global Equine Influenza Vaccine market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Equine Influenza Vaccine industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Equine Influenza Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Equine Influenza Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Zoetis
Merck Animal Health
Boehringer Ingelheim Vetmedica
Segment by Type
Liquid
Powder

Segment by Application


Home
Pet Clinic
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Equine Influenza Vaccine plant distribution, commercial date of Equine Influenza Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Equine Influenza Vaccine introduction, etc. Equine Influenza Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Equine Influenza Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Equine Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Equine Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Liquid
1.2.3 Powder
1.3 Market by Application
1.3.1 Global Equine Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Home
1.3.3 Pet Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Equine Influenza Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Equine Influenza Vaccine Revenue by Region
2.2.1 Global Equine Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Equine Influenza Vaccine Revenue by Region (2018-2024)
2.2.3 Global Equine Influenza Vaccine Revenue by Region (2024-2029)
2.2.4 Global Equine Influenza Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Equine Influenza Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Equine Influenza Vaccine Sales by Region
2.4.1 Global Equine Influenza Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Equine Influenza Vaccine Sales by Region (2018-2024)
2.4.3 Global Equine Influenza Vaccine Sales by Region (2024-2029)
2.4.4 Global Equine Influenza Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Equine Influenza Vaccine Sales by Manufacturers
3.1.1 Global Equine Influenza Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Equine Influenza Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Equine Influenza Vaccine in 2022
3.2 Global Equine Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Equine Influenza Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Equine Influenza Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Equine Influenza Vaccine Revenue in 2022
3.3 Global Key Players of Equine Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Equine Influenza Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Equine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Equine Influenza Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Equine Influenza Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Equine Influenza Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Equine Influenza Vaccine Sales by Type
4.1.1 Global Equine Influenza Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Equine Influenza Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Equine Influenza Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Equine Influenza Vaccine Revenue by Type
4.2.1 Global Equine Influenza Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Equine Influenza Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Equine Influenza Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Equine Influenza Vaccine Price by Type
4.3.1 Global Equine Influenza Vaccine Price by Type (2018-2024)
4.3.2 Global Equine Influenza Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Equine Influenza Vaccine Sales by Application
5.1.1 Global Equine Influenza Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Equine Influenza Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Equine Influenza Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Equine Influenza Vaccine Revenue by Application
5.2.1 Global Equine Influenza Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Equine Influenza Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Equine Influenza Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Equine Influenza Vaccine Price by Application
5.3.1 Global Equine Influenza Vaccine Price by Application (2018-2024)
5.3.2 Global Equine Influenza Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Equine Influenza Vaccine Market Size by Type
6.1.1 US & Canada Equine Influenza Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Equine Influenza Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Equine Influenza Vaccine Market Size by Application
6.2.1 US & Canada Equine Influenza Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Equine Influenza Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Equine Influenza Vaccine Market Size by Country
6.3.1 US & Canada Equine Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Equine Influenza Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Equine Influenza Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Equine Influenza Vaccine Market Size by Type
7.1.1 Europe Equine Influenza Vaccine Sales by Type (2018-2029)
7.1.2 Europe Equine Influenza Vaccine Revenue by Type (2018-2029)
7.2 Europe Equine Influenza Vaccine Market Size by Application
7.2.1 Europe Equine Influenza Vaccine Sales by Application (2018-2029)
7.2.2 Europe Equine Influenza Vaccine Revenue by Application (2018-2029)
7.3 Europe Equine Influenza Vaccine Market Size by Country
7.3.1 Europe Equine Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Equine Influenza Vaccine Sales by Country (2018-2029)
7.3.3 Europe Equine Influenza Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Equine Influenza Vaccine Market Size
8.1.1 China Equine Influenza Vaccine Sales (2018-2029)
8.1.2 China Equine Influenza Vaccine Revenue (2018-2029)
8.2 China Equine Influenza Vaccine Market Size by Application
8.2.1 China Equine Influenza Vaccine Sales by Application (2018-2029)
8.2.2 China Equine Influenza Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Equine Influenza Vaccine Market Size by Type
9.1.1 Asia Equine Influenza Vaccine Sales by Type (2018-2029)
9.1.2 Asia Equine Influenza Vaccine Revenue by Type (2018-2029)
9.2 Asia Equine Influenza Vaccine Market Size by Application
9.2.1 Asia Equine Influenza Vaccine Sales by Application (2018-2029)
9.2.2 Asia Equine Influenza Vaccine Revenue by Application (2018-2029)
9.3 Asia Equine Influenza Vaccine Sales by Region
9.3.1 Asia Equine Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Equine Influenza Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Equine Influenza Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Equine Influenza Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Equine Influenza Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Equine Influenza Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Equine Influenza Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Equine Influenza Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Equine Influenza Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Equine Influenza Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Equine Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Equine Influenza Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Equine Influenza Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Company Information
11.1.2 Zoetis Overview
11.1.3 Zoetis Equine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Zoetis Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Zoetis Recent Developments
11.2 Merck Animal Health
11.2.1 Merck Animal Health Company Information
11.2.2 Merck Animal Health Overview
11.2.3 Merck Animal Health Equine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck Animal Health Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Animal Health Recent Developments
11.3 Boehringer Ingelheim Vetmedica
11.3.1 Boehringer Ingelheim Vetmedica Company Information
11.3.2 Boehringer Ingelheim Vetmedica Overview
11.3.3 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Vetmedica Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Equine Influenza Vaccine Industry Chain Analysis
12.2 Equine Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Equine Influenza Vaccine Production Mode & Process
12.4 Equine Influenza Vaccine Sales and Marketing
12.4.1 Equine Influenza Vaccine Sales Channels
12.4.2 Equine Influenza Vaccine Distributors
12.5 Equine Influenza Vaccine Customers
13 Market Dynamics
13.1 Equine Influenza Vaccine Industry Trends
13.2 Equine Influenza Vaccine Market Drivers
13.3 Equine Influenza Vaccine Market Challenges
13.4 Equine Influenza Vaccine Market Restraints
14 Key Findings in The Global Equine Influenza Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Equine Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Liquid
Table 3. Major Manufacturers of Powder
Table 4. Global Equine Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Equine Influenza Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Equine Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Equine Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Equine Influenza Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Equine Influenza Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Equine Influenza Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Equine Influenza Vaccine Sales by Region (2018-2024) & (K Doses)
Table 12. Global Equine Influenza Vaccine Sales by Region (2024-2029) & (K Doses)
Table 13. Global Equine Influenza Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Equine Influenza Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Equine Influenza Vaccine Sales by Manufacturers (2018-2024) & (K Doses)
Table 16. Global Equine Influenza Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Equine Influenza Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Equine Influenza Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Equine Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Equine Influenza Vaccine Price by Manufacturers 2018-2024 (USD/Dose)
Table 21. Global Equine Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Equine Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Influenza Vaccine as of 2022)
Table 23. Global Key Manufacturers of Equine Influenza Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Equine Influenza Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Equine Influenza Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Equine Influenza Vaccine Sales by Type (2018-2024) & (K Doses)
Table 28. Global Equine Influenza Vaccine Sales by Type (2024-2029) & (K Doses)
Table 29. Global Equine Influenza Vaccine Sales Share by Type (2018-2024)
Table 30. Global Equine Influenza Vaccine Sales Share by Type (2024-2029)
Table 31. Global Equine Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Equine Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Equine Influenza Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Equine Influenza Vaccine Revenue Share by Type (2024-2029)
Table 35. Equine Influenza Vaccine Price by Type (2018-2024) & (USD/Dose)
Table 36. Global Equine Influenza Vaccine Price Forecast by Type (2024-2029) & (USD/Dose)
Table 37. Global Equine Influenza Vaccine Sales by Application (2018-2024) & (K Doses)
Table 38. Global Equine Influenza Vaccine Sales by Application (2024-2029) & (K Doses)
Table 39. Global Equine Influenza Vaccine Sales Share by Application (2018-2024)
Table 40. Global Equine Influenza Vaccine Sales Share by Application (2024-2029)
Table 41. Global Equine Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Equine Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Equine Influenza Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Equine Influenza Vaccine Revenue Share by Application (2024-2029)
Table 45. Equine Influenza Vaccine Price by Application (2018-2024) & (USD/Dose)
Table 46. Global Equine Influenza Vaccine Price Forecast by Application (2024-2029) & (USD/Dose)
Table 47. US & Canada Equine Influenza Vaccine Sales by Type (2018-2024) & (K Doses)
Table 48. US & Canada Equine Influenza Vaccine Sales by Type (2024-2029) & (K Doses)
Table 49. US & Canada Equine Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Equine Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Equine Influenza Vaccine Sales by Application (2018-2024) & (K Doses)
Table 52. US & Canada Equine Influenza Vaccine Sales by Application (2024-2029) & (K Doses)
Table 53. US & Canada Equine Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Equine Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Equine Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Equine Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Equine Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Equine Influenza Vaccine Sales by Country (2018-2024) & (K Doses)
Table 59. US & Canada Equine Influenza Vaccine Sales by Country (2024-2029) & (K Doses)
Table 60. Europe Equine Influenza Vaccine Sales by Type (2018-2024) & (K Doses)
Table 61. Europe Equine Influenza Vaccine Sales by Type (2024-2029) & (K Doses)
Table 62. Europe Equine Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Equine Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Equine Influenza Vaccine Sales by Application (2018-2024) & (K Doses)
Table 65. Europe Equine Influenza Vaccine Sales by Application (2024-2029) & (K Doses)
Table 66. Europe Equine Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Equine Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Equine Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Equine Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Equine Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Equine Influenza Vaccine Sales by Country (2018-2024) & (K Doses)
Table 72. Europe Equine Influenza Vaccine Sales by Country (2024-2029) & (K Doses)
Table 73. China Equine Influenza Vaccine Sales by Type (2018-2024) & (K Doses)
Table 74. China Equine Influenza Vaccine Sales by Type (2024-2029) & (K Doses)
Table 75. China Equine Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Equine Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Equine Influenza Vaccine Sales by Application (2018-2024) & (K Doses)
Table 78. China Equine Influenza Vaccine Sales by Application (2024-2029) & (K Doses)
Table 79. China Equine Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Equine Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Equine Influenza Vaccine Sales by Type (2018-2024) & (K Doses)
Table 82. Asia Equine Influenza Vaccine Sales by Type (2024-2029) & (K Doses)
Table 83. Asia Equine Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Equine Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Equine Influenza Vaccine Sales by Application (2018-2024) & (K Doses)
Table 86. Asia Equine Influenza Vaccine Sales by Application (2024-2029) & (K Doses)
Table 87. Asia Equine Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Equine Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Equine Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Equine Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Equine Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Equine Influenza Vaccine Sales by Region (2018-2024) & (K Doses)
Table 93. Asia Equine Influenza Vaccine Sales by Region (2024-2029) & (K Doses)
Table 94. Middle East, Africa and Latin America Equine Influenza Vaccine Sales by Type (2018-2024) & (K Doses)
Table 95. Middle East, Africa and Latin America Equine Influenza Vaccine Sales by Type (2024-2029) & (K Doses)
Table 96. Middle East, Africa and Latin America Equine Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Equine Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Equine Influenza Vaccine Sales by Application (2018-2024) & (K Doses)
Table 99. Middle East, Africa and Latin America Equine Influenza Vaccine Sales by Application (2024-2029) & (K Doses)
Table 100. Middle East, Africa and Latin America Equine Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Equine Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Equine Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Equine Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Equine Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Equine Influenza Vaccine Sales by Country (2018-2024) & (K Doses)
Table 106. Middle East, Africa and Latin America Equine Influenza Vaccine Sales by Country (2024-2029) & (K Doses)
Table 107. Zoetis Company Information
Table 108. Zoetis Description and Major Businesses
Table 109. Zoetis Equine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 110. Zoetis Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Zoetis Recent Developments
Table 112. Merck Animal Health Company Information
Table 113. Merck Animal Health Description and Major Businesses
Table 114. Merck Animal Health Equine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 115. Merck Animal Health Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Animal Health Recent Developments
Table 117. Boehringer Ingelheim Vetmedica Company Information
Table 118. Boehringer Ingelheim Vetmedica Description and Major Businesses
Table 119. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 120. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Boehringer Ingelheim Vetmedica Recent Developments
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Equine Influenza Vaccine Distributors List
Table 125. Equine Influenza Vaccine Customers List
Table 126. Equine Influenza Vaccine Market Trends
Table 127. Equine Influenza Vaccine Market Drivers
Table 128. Equine Influenza Vaccine Market Challenges
Table 129. Equine Influenza Vaccine Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Equine Influenza Vaccine Product Picture
Figure 2. Global Equine Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Equine Influenza Vaccine Market Share by Type in 2022 & 2029
Figure 4. Liquid Product Picture
Figure 5. Powder Product Picture
Figure 6. Global Equine Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Equine Influenza Vaccine Market Share by Application in 2022 & 2029
Figure 8. Home
Figure 9. Pet Clinic
Figure 10. Others
Figure 11. Equine Influenza Vaccine Report Years Considered
Figure 12. Global Equine Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Equine Influenza Vaccine Revenue 2018-2029 (US$ Million)
Figure 14. Global Equine Influenza Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Equine Influenza Vaccine Revenue Market Share by Region (2018-2029)
Figure 16. Global Equine Influenza Vaccine Sales 2018-2029 ((K Doses)
Figure 17. Global Equine Influenza Vaccine Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Equine Influenza Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 19. US & Canada Equine Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Equine Influenza Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 21. Europe Equine Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Equine Influenza Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 23. China Equine Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Equine Influenza Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 25. Asia (excluding China) Equine Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Equine Influenza Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 27. Middle East, Africa and Latin America Equine Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Equine Influenza Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Equine Influenza Vaccine in the World: Market Share by Equine Influenza Vaccine Revenue in 2022
Figure 30. Global Equine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Equine Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 32. Global Equine Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 33. Global Equine Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 34. Global Equine Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Equine Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Equine Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Equine Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Equine Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Equine Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 40. US & Canada Equine Influenza Vaccine Sales Share by Country (2018-2029)
Figure 41. U.S. Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Equine Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 44. Europe Equine Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 45. Europe Equine Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 46. Europe Equine Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 47. Europe Equine Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 48. Europe Equine Influenza Vaccine Sales Share by Country (2018-2029)
Figure 49. Germany Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. France Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. China Equine Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 55. China Equine Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 56. China Equine Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 57. China Equine Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 58. Asia Equine Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 59. Asia Equine Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 60. Asia Equine Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 61. Asia Equine Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 62. Asia Equine Influenza Vaccine Revenue Share by Region (2018-2029)
Figure 63. Asia Equine Influenza Vaccine Sales Share by Region (2018-2029)
Figure 64. Japan Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. India Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Equine Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Equine Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Equine Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Equine Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Equine Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Equine Influenza Vaccine Sales Share by Country (2018-2029)
Figure 75. Brazil Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Equine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. Equine Influenza Vaccine Value Chain
Figure 81. Equine Influenza Vaccine Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries